1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Biomarkers Market: Types (Biomarkers: Disease & related, Imaging, Others) Application (Drug Discovery, Bioinformatics, Others) Therapeutic Areas (Cardiology, Neurology, Others) Products (Hormones, Enzymes, Others) End Users (Hospitals, Others)-Forecast(20

Biomarkers are biological molecules which act as indicator of a particular disease state or pharmacological conditions. Advancement in post genomic technologies, increasing R&D spending and dynamic applications of biomarkers in medicine will drive the future market growth.

The market for Biomarkers is classified into five categories based on types, application areas, therapeutic segments, products and by end users, each of these segments are further broken down into sub-segments to give a comprehensive analysis of global biomarkers market.

The overall market has also been presented from the perspective of different geographic locations and key economies in this market. Competitors are highlighted and market players are profiled with attributes covering company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of each of the prominent players for 2014 are detailed.

The market is largely dominated by North America which accounted for about half of the global share. APAC is a promising market and is opening gateways for new manufacturers.

The report also provides a detailed qualitative analysis of the factors responsible for driving and hindering the growth of the Biomarkers market and future opportunities that can propel the market.

The report contains the most detailed and in-depth segmentation and analysis of the Global Biomarkers Market during the forecast period 2014 - 2020.

Table Of Contents

Biomarkers Market: Types (Biomarkers: Disease and related, Imaging, Others) Application (Drug Discovery, Bioinformatics, Others) Therapeutic Areas (Cardiology, Neurology, Others) Products (Hormones, Enzymes, Others) End Users (Hospitals, Others)-Forecast(20
1. Global Biomarkers Market - Market Overview
2. Executive Summary
3. Global Biomarkers Market - Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. Patent Analysis
3.2.3. End user profiling
3.2.4. Top 5 Financials Analysis
4. Global Biomarkers Market- Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Global Biomarkers Market - Strategic Analysis
5.1. Value Chain Analysis
5.2. Opportunities Analysis
5.3. Product lifecycle
5.4. Pricing Analysis
6. Global Biomarkers Market- By Types
6.1. Disease-related biomarkers
6.1.1. Diagnostic biomarker
6.1.2. Prognostic biomarker
6.2. Drug-related biomarkers
6.3. Imaging biomarkers
6.4. Molecular biomarkers
6.5. Surrogate biomarkers
6.6. Others
7. Global Biomarkers Market- By Application
7.1. Drug discovery and Development
7.2. Molecular diagnostics
7.3. Genetic studies
7.4. Clinical Trials
7.5. Bioinformatics
7.6. Others
8. Global Biomarkers Market- By Therapeutic areas
8.1. Oncology
8.2. Cardiology
8.3. Immunology
8.4. Neurology
8.5. Others
9. Global Biomarkers Market- By Products
9.1. Hormones
9.2. Enzymes
9.3. Antibodies
9.4. Gene products
9.5. Others
10. Global Biomarkers Market- By End Users
10.1. Pharmaceutical Companies
10.2. Hospitals
10.3. Research Institutes
10.4. CROs
10.5. Diagnostic Labs
11. Global Biomarkers Market -Geographic Analysis
11.1. North America
11.1.1. Canada
11.1.2. Mexico
11.1.3. USA
11.1.4. Others
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Sweden
11.2.5. U.K
11.2.6. Others
11.3. APAC
11.3.1. China
11.3.2. India
11.3.3. Japan
11.3.4. Australia
11.3.5. Others
11.4. ROW
11.4.1. South Africa
11.4.2. South America
11.4.3. Russia
11.4.4. Saudi Arabia
11.4.5. Others
12. Market Entropy
12.1. New Product Launches
12.2. MandAs, Collaborations, JVs and Partnerships
13. Company profiles
13.1. Qiagen N.V.
13.2. PerkinElmer, Inc.
13.3. Merck and Co, Inc.
13.4. Bio-Rad Laboratories
13.5. Enzo Biochem
13.6. EKF Diagnostics Holdings plc
13.7. Meso Scale Diagnostics, LLC
13.8. Singulex, Inc.
13.9. BioSims Technologies
13.10. Cisbio Bioassays
13.11. Signosis, Inc.
13.12. Roche Diagnostic Limited
13.13. Siemens Healthcare
13.14. Abbott Laboratories Inc.
13.15. Thermo Fisher Scientific, Inc.
13.16. Agilent Technologies Inc.
13.17. Aushon BioSystem Inc.
13.18. Epistem Ltd
13.19. G.E. Healthcare Inc.
13.20. Beckman Coulter, Inc.
13.21. Biomoda, Inc.
13.22. Epigenomics AG
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
14. Appendix
14.1. Abbreviations
14.2. Sources
14.3. Research Methodology
14.4. Bibliography
14.5. Compilation of Expert Insights
14.6. Disclaimer

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Biobanking: Technologies and Global Markets

Biobanking: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

Use this report to: - Analyze the role biobanks play in the development of new drugs for specific disease treatments. - Learn about the prevailing market size for certain biobank services available ...

Cardiac Biomarkers Market By Type, By Application, By End Use, By Region And Segment Forecasts to 2024

Cardiac Biomarkers Market By Type, By Application, By End Use, By Region And Segment Forecasts to 2024

  • $ 4950
  • Industry report
  • September 2016
  • by Grand View Research

The cardiac biomarkers market is expected to reach USD13.3 billion by 2024, according to a new report by Grand View Research, Inc. The cardiac biomarkers market is anticipated to witness a lucrative growth ...

Cancer Biomarkers - Global Market Outlook (2016-2022)

Cancer Biomarkers - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Cancer Biomarkers market is estimated at $9215.32 million in 2015 and is expected to reach $20958.63 million by 2022 growing at a CAGR of 12.5% from 2015 to 2022. ...


Download Unlimited Documents from Trusted Public Sources

Genetic Industry in the US

  • November 2016
    10 pages
  • Genetic  

    Cardiovascular ...  

  • United States  

View report >

Genetic Industry in the UK

  • November 2016
    26 pages
  • Genetic  

  • United Kingdom  

    Europe  

View report >

Genetic Industry in the UK

  • November 2016
    26 pages
  • Genetic  

  • United Kingdom  

    Europe  

View report >

Related Market Segments :

Biomarker

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.